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Abstract
Background: The CareGiver Oncology Quality of Life (CarGOQoL) questionnaire, a 29-item, multidimensional,
self-administered questionnaire, was validated using a large French sample. We reported the linguistic validation
process and the metric validity of the English version of CarGOQoL in the United- States.
Methods: The translation process consisted of 3 consecutive steps: forward-backward translation, acceptability
testing, and cognitive interviews. The psychometric testing was applied to caregivers of consecutive patients with
representative cancers who were recruited from the Regional Cancer Center in northwestern Pennsylvania. All
individuals completed the CarGOQoL at baseline, day- 30, and day- 90. Internal consistency, reliability, external
validity, reproducibility, and sensitivity to change were tested.
Results: The translated version was validated on a total of 87 American cancer caregivers. The dimensions of the
CarGOQoL generally demonstrated a high internal consistency (Cronbach’s alpha > 0.70 for all but four domain
scores). External validity testing revealed that the CarGOQoL index score correlated significantly with all SF-36
dimension scores except the physical composite score (Pearson’s correlation: 0.28–0.70). Reproducibility was
satisfactory at day- 30 (intraclass correlation coefficient: 0.46–0.94) and day- 90 (0.43–0.92). Four specific dimensions
of CarGOQoL showed responsiveness: the Psychological well-being, the Relationships with health care system, the
Social support and the Finances.
Conclusions: The American version of the CarGOQoL constitutes a useful instrument to measure QoL in caregivers
of cancer patients in the United- States.
Keywords: CarGOQoL, Caregivers, Cancer, Quality of life, Validation, Questionnaire
Background
In recent decades, the progress in cancer treatment and
cancer detection has been considerable. This has ren-
dered cancer, in many cases, a chronic illness, thereby
resulting in difficulties for patients and caregivers [1, 2].
It has been recognized that caregiving adversely effects
the caregiver in terms of their health, emotional status
[3–6], and quality of life (QoL) [7, 8].
Several groups have published detailed recommenda-
tions for the QoL assessment of caregivers. This is
considered increasingly important with regard to evalu-
ating the management of care provided to patients with
chronic diseases [9–11]. QoL is commonly self-reported,
and questionnaires must be robust, valid, and reliable,
and must implement universally applied measures. Inter-
views with patients are commonly considered the best
method to capture the patient’s perceptions.
Among the instruments used to measure the QoL of
cancer caregivers [12], only three self-administered in-
struments were specifically developed for caregiver’ pop-
ulations using standard methods: the Caregiver Quality
of Life Index (CQLI) [13], the Caregiver Quality of Life
Index-Cancer Scale (CQOLC) [14], and, most recently,
the CareGiver Oncology Quality of Life (CarGOQoL)
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questionnaire [15]. The CQLI is a straightforward ques-
tionnaire that was validated using a sample of five sub-
jects, who were asked only to indicate the relevance of
predefined items. The CQOLC, which has been more
thoroughly developed, was based on a mixed approach
combining interviews with patient-caregiver dyads and
experts’ points of view and was validated using a homo-
geneous sample comprised only of spouses. The CarGO-
QoL is the only questionnaire that meets the following
criteria: i) based on the caregivers’ exclusive point of
view (involving the content analysis of 77 face-to-face
semi-structured interviews performed by experienced
professionals), which is now recognized as the best ap-
proach to develop a questionnaire based on a clear con-
ceptual basis for QoL [16–18]; ii) validated in a large
heterogeneous sample of caregivers including partners,
parents and children; and iii) capturing specific dimen-
sions, such as self-esteem or private life. However, the
CarGOQoL is solely available in the French language.
We report the linguistic validation process and the




Study participants were required to be: at least 18 years
of age, designated by the patient as a ‘natural caregiver’
(‘the non-institutional relative/person who is taking care
most of me and who is not paid to provide care’), able to
speak/read English, and free from cancer comorbidity.
Patients were selected from a community oncology prac-
tice in northwestern Pennsylvania (the Regional Cancer
Center). Patients were diagnosed with either localized or
metastatic primary cancer (leukemia, breast cancer, uro-
logic cancer, melanoma, digestive cancer, lung cancer,
and others). Caregivers were enrolled between July 2013
and February 2015.
Ethics, consent and permissions
The participants all signed a written consent. The study
was approved by The Saint Vincent Institutional Review
Board (April 18, 2013; office number 814-452-5272).
Study design and data collection
Caregivers were evaluated upon enrolment and were re-
evaluated at 1 and 3 months. General characteristics re-
lated to the caregiver and the patient were collected
upon inclusion. Self-administered survey materials were
handed out and completed by the caregivers during the
3 evaluation times. These materials included the CarGO-
QoL questionnaire, the generic 36 Item Short Form (SF-
36) questionnaire, and two visual analogic scales (VAS)
to assess QoL and burden on a scale from 0 to 10. At
the 1- and 3-month evaluations, caregivers were asked
closed-ended questions about important (negative and/
or positive) changes in their own lives since enrolment
and about their perceptions of changes in the patient’s
health (improved/stable/deteriorated).
General characteristics
The following parameters were collected from the
caregivers: gender, age, marital status, nature of the rela-
tionship with the patient, and caregiving duration. The
following parameters were collected from the patients:
gender, age, cancer localization, disease duration, stage,
performance status.
Quality of life: CareGiver Oncology Quality of Life
questionnaire and the short-form 36
The CarGOQoL is a well-validated specific question-
naire for caregivers of cancer patients in France [15] that
includes 29 questions describing 10 dimensions: psycho-
logical well-being, burden, relationship with health care,
administration and finances, coping, physical wellbeing,
self-esteem, leisure time, social support and private life.
An index was computed. SF-36 questionnaire comprises
36 items that are used to calculate the following eight
scale scores: physical functioning, social functioning,
role–physical, role–emotional, mental health, vitality,
bodily pain, and general health [19]. Two composite
summary measures were also calculated: the Physical
Component Summary (PCS) and the Mental Compo-
nent Summary (MCS) scores. The PCS and MCS scores
were norm-based using a linear T-score transformation
with a mean of 50 and a standard deviation (SD) of 10.
Both the CarGOQoL and the SF-36 questionnaires
yielded scores on a 0–100 scale, where 0 represents the
lowest QoL level and 100 represents the highest QoL
level.
General organization
The development and linguistic validation of a ques-
tionnaire should be based on a unique methodology
and acknowledged by health authorities, ethics’ com-
mittees, and researchers in the field [20]. Two main
steps were organized as follows: 1. the translation
and the cultural adaptation process;and 2. psycho-
metric testing. The two steps were planned under
the coordination of a team that included the American
clinical partners (two members of the Regional Cancer
Center in northwestern Pennsylvania, United States of
America) and the French developers of the CarGOQoL
(two members of the Self-perceived Health Assessment
Research Unit, Aix-Marseille University, Marseille,
France).
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Translation and cultural adaptation process
The developers (PM, PA) provided a conceptual defin-
ition of the original items (termed “list of concepts”) to
clarify the notions investigated in each item of the original
French questionnaire. This list allowed for clarifying the
notions investigated in each item of the original question-
naire in order to enhance harmonization across all lan-
guage versions. The translation and the cultural
adaptation processes were organized into several steps.
First, forward translation of the CarGOQoL questionnaire
from French into the target language (English) was per-
formed by two native English speakers who were also flu-
ent in French. Any differences between the 2 translated
versions were discussed by the translators and the devel-
opers, thereby ensuring conceptual equivalence. A recon-
ciled, harmonized, and agreed upon forward-translated
version of the CarGOQoL was produced. Second, back-
ward translation of this version into English was per-
formed by two native French speakers who were also
fluent in English. Any differences between the original
French version and the back-translated version were dis-
cussed by the translators and the developers. A back-
translated English version was produced. Third, accept-
ability testing was performed on a small sample (from 6 to
10) of cancer caregivers. The understandability, misinter-
pretation, and acceptability were checked. Some terms
were reworded and a new version was produced
Psychometric testing
The latest version was validated in a larger sample of
caregivers in order to test the psychometric properties
and to check the reliability and sensitivity.
Statistical analyses
The linguistic transcultural equivalence was ensured by
the collaboration between the American physicians and
the French developers. The psychometric testing was
performed using the following procedure.
A confirmatory factor analysis (CFA) was performed
using the LISREL model. The fit to the model was
tested by computing the Root Mean Square Error of
Approximation (RMSEA), and a value <0.08 was
considered acceptable. Internal structural validity was
assessed using item-dimension correlations: item
internal consistency (IIC) was assessed by correlating
each item with its scale (a correlation of 0.4 sup-
ported item internal consistency (IIC)), and item
discriminant validity (IDV) was assessed by determin-
ing the extent to which items correlates with the
dimension they are hypothesized to represent than
with the other ones. Floor and ceiling effects were
reported assessing the homogeneous repartition of the
response distribution. For each dimension, internal
consistency reliability was assessed using Cronbach’s
alpha coefficient. A Cronbach’s alpha coefficient of at
least 0.7 was expected for each scale [21]. The unidi-
mensionality of each scale was assessed using Rasch
analyses: item goodness-of-fit statistics (INFIT) and
coefficient of Loevinger (H). INFIT statistics ranging
between 0.7 and 1.2 and an H coefficient of at least
0.40 ensure that all the items of the scale tend to
measure the same concept [22]. Differential item
functioning (DIF) analyses were performed to com-
pare the differences in item difficulties between the
American caregivers and the French caregivers
assessed in the CarGOQoL validation study [15].
To explore external validity, relations between the fol-
lowing dimensions were assessed using Pearson’s correl-
ation coefficients (r): i) dimensions of CarGOQoL and
the SF-36; and ii) dimensions of CarGOQoL and the
VAS of burden/QoL. The underlying assumption was
that the dimension scores of the CarGOQoL would bet-
ter correlate with the scores of similar dimensions from
the SF-36 than with dissimilar dimensions [15]. The dis-
criminant validity was determined by assessing the asso-
ciations between the CarGOQoL dimension scores and
sociodemographic and clinical features. For qualitative
variables, the mean dimension scores of the CarGOQoL
were compared across patient groups that were expected
to differ (e.g. gender, marital status, relationship, age
classes) using Student’s t test. Quantitative variables (e.g.
caregiving duration and disease duration), were analyzed
using Pearson’s correlation coefficients. The underlying
assumptions were derived from the initial validation of
CarGOQoL [15]: women should report lower scores for
emotional dimensions than men, caregivers who were
single and who were children should report lower QoL,
and patient’s disease duration and caregiving duration
should be correlated to some dimensions of QoL.
Reproducibility was tested by assessing the test–re-test
reliability using intraclass correlation coefficients (ICC)
between the two successive assessments in stable care-
givers who were defined in two ways: i) caregivers
reporting no life events and ii) caregivers reporting no
health changes of the patient. Sensitivity to change was
tested through comparisons of the mean scores between
the two successive assessments in caregivers who re-
ported improved or worsened health statuses of the pa-
tient. Data analyses were performed using SPSS 11.0,
MAP-R, and WINSTEP software.
Results
Sample characteristics
The study sample included 87 American caregivers of
cancer patients. Table 1 details the different characteris-
tics of the caregivers and patients. The mean (standard
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deviation) age of caregivers was 60 (standard deviation
11) years. In 65 % of cases, the caregiver was the spouse
of the patient. The median caregiving duration was
8 years (interquartile 3–30). The most frequent locations
of the patients’ cancer were breast and lung.
Construct validity and internal structural validity
The structure was confirmed using CFA, which showed
a reasonable fit (RMSEA at 0.800). There were no differ-
ences in the DIF results between the American individ-
uals and the French sample [15] for all of the items. All
of the correlations of each item with its contributive di-
mension and with the other dimensions are presented in
Table 2, which shows overlapping of some dimensions.
Floor and ceiling effects were considered satisfactory
(the ceiling effects of 3 dimensions were higher than
25 % of the Burden, Administration and finances, and
Social support dimensions). Six dimensions of the Car-
GOQoL showed satisfactory internal consistency (Cron-
bach’s alpha: 0.71–0.87). Eight dimensions showed a
satisfactory scalability. The Burden and the Relationship
with healthcare dimensions (Burden, item 8 “… been
embarrassed to be the only person to provide assist-
ance”; Relationship with healthcare, item 10 “… been
reassured by the health care providers” and item 11 “…
felt that your role as caregiver was recognized by health
care providers”) showed an INFIT statistics outside the
acceptable ranges. All of the results are provided in
Table 2.
External validity and discriminant validity
The concepts covered by the CarGOQoL and the SF-36
do not systematically overlap. In particular, some specific
dimensions of CarGOQoL, including Relationship with
healthcare and Self-esteem, were not correlated with the
SF-36 dimensions. As expected, the ‘emotional-like’ di-
mensions of the CarGOQoL (Psychological well-being,
Burden, and Coping) were moderately to highly corre-
lated with the ‘emotional-like’ dimensions of SF-36 (Role
emotional, Mental health, and the Mental composite
score). Leisure and Private life were moderately corre-
lated with the Social functioning score of SF-36. The
Burden score was significantly correlated with the visual
analogic scale of Burden. The index was significantly
correlated with the VAS of QoL. All correlations are de-
tailed in Table 3.
The discriminant validity of CarGOQoL was assessed
using the clinical and sociodemographic characteristics
(Table 4). Women reported significantly lower scores in
the Psychological well-being dimension. Caregivers living
with a partner reported significantly better QoL in 2 di-
mensions: Administration and finances and Coping.
Caregivers who were children and who were younger re-
ported significantly lower scores in 3 and 2 dimensions.
The age and gender of the caregivers were negatively
linked to the caregivers’ QoL in some dimensions.
Reproducibility and sensitivity to change
The numbers of patients defined as stable based on the
absence of self-reported positive/negative events in their
life between 2 assessments were 17 on day- 30 and 19 in
day- 90; the numbers of patients defined as stable based
on the absence of self-reported health changes between
2 assessments were 39 on day- 30 and 29 on day- 90.
The test-retest reliability at day- 30 was satisfactory
showing an ICC ranging from 0–53 to 0.94, except for
Relationship with healthcare and Private life (0.46 and
0.48, respectively). The reliability on day- 90 was also
satisfactory, with an ICC higher than 0.50 for all
Table 1 Baseline characteristics
N = 87
1. Caregivers
Gender Women 58 (68.2)
Men 27 (31.8)
Age (years) Mean ± SDa 60.0 ± 11.2
Living With a partner 72 (84.7)
Alone 13 (15.3)
Relationship with the patient Partner 55 (64.7)
Children 12 (14.1)
Othersc 18 (21.2)
Time of caregiving (months) Median [IQR]b 8 [3–30]
2. Patients
Gender Women 43 (51.2)
Men 41 (48.8)
Age (years) Mean ± SDa 65.0 ± 12.8
Cancer location Breast 23 (26.4)
Lung 22 (25.3)
Head and neck 10 (11.5)
Hematologic 8 (9.2)
Othersd 24 (27.6)





Disease duration (months) Median [IQR]b 11 [6–44]
WHO PS 0 50 (59.5)
> = 1 34 (40.5)
a SD standard deviation
b IQR interquartile range
c friend (5), brother/sister (4), parent (4), unknown (5)
d urogenital (12), digestive (7), thyroid (1), knee (1), unknown primary (3)
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dimensions except Relationship with healthcare and
Self-esteem. All of these results are presented in Table 5.
Sensitivity to change was tested on a sub-sample in
which the patients’ health statuses either improved or
worsened. The questionnaire was not sensitive to the
change in the patient’s health status, except in the Leis-
ure time dimension at day- 30 and in the Psychological
well-being, Relationship with healthcare, Social support,
and Administration and finances dimensions at day- 90.
All these details are presented in Table 6.
Acceptability
The median time for completion of the questionnaire
was 6 min, with an interquartile range of 4 to 11. The
missing data were very low (less than 0.5 %).
Discussion
The CarGOQoL is a well-designed and well-validated
questionnaire assessing QoL of cancer caregivers. The
CarGOQoL was developed in France, and we reported
the validation of the American version of the CarGO-
QoL in the United-States. To answer the scientific
and regulatory requirements that are specific to this
field, the development and linguistic validation should
be based on a unique methodology acknowledged by
health authorities, ethics’ committees, and researchers
in the field [20]. The rigorous linguistic validation
process that we used in this work ensures that the
original concepts and content validity were retained,
and that cross-cultural differences related to health
between different countries were taken into account.
Table 2 Dimensions’ characteristics of CargoQoL
Dimension (Items) N Mean ± SDa IIC min - max IDV min - max % floor effect % ceiling effect Alpha INFIT min-max
Psychological well being (4) 85 47,7 ± 22,0 0.67–0.78 −0.16–0.64 0 2.6 0.87 0.78–1.28
Burden (4) 85 83,8 ± 18,7 0.23–0.82 −0.13–0.55 0 29.5 0.79 0.73–2.06
Relationship with healthcare (3) 85 74,1 ± 17,0 0.19–0.42 −0.18–0.38 0 10.3 0.57 0.62–1.38
Administration and finances (3) 83 80,8 ± 20,5 0.42–0.60 −0.11–0.48 0 30.8 0.71 0.77–1.23
Coping (3) 84 68,3 ± 20,2 0.37–0.51 −0.11–0.55 0 11.5 0.64 0.84–1.22
Physical well being (4) 84 69,4 ± 21,0 0.56–0.68 −0.21–0.67 0 6.4 0.81 0.79–1.24
Self-esteem (2) 85 74,1 ± 20,7 0.62–0.62 −0.15–0.22 0 20.5 0.75 0.97–1.13
Leisure time (2) 85 54,8 ± 20,3 0.45–0.45 −0.14–0.48 0 1.3 0.60 0.89–0.99
Social support (2) 85 72,7 ± 22,0 0.61–0.61 0.04–0.33 0 25.6 0.76 0.95–1.02
Private life (2) 80 50,6 ± 22,8 0.15–0.15 −0.17–0.47 1.3 5.1 0.26 0.97–1.04
Index 78 67,6 ± 11,8
M± SD mean ± standard deviation; ICC item internal consistency; IDV item discriminant validity; Alpha Cronbach’s alpha; INFIT Rasch statistics
a scores ranging from 0 to 100; the higher the score, the better the QoL
Table 3 Correlations between CargoQoL dimensions and other self-reported measures
PsWB B RHC AF COP PhWB SE LEI SS PL Index
SF-36 Physical functioning 0,216* 0,139 0,103 0,164 0,177 0,207 0,028 0,241* 0,269* 0,266* 0,284*
Social functioning 0,668** 0,623** 0,154 0,454** 0,514** 0,578** 0,017 0,514** 0,259* 0,469** 0,702**
Role physical 0,372** 0,308** 0,040 0,309** 0,409** 0,446** −0,040 0,334** 0,320** 0,344** 0,480**
Role emotional 0,618** 0,438** 0,129 0,290** 0,528** 0,635** 0,160 0,371** 0,313** 0,394** 0,642**
Mental health 0,722** 0,436** 0,098 0,339** 0,600** 0,587** 0,268* 0,478** 0,264* 0,338** 0,671**
Vitality 0,535** 0,386** 0,090 0,252* 0,436** 0,583** 0,166 0,526** 0,373** 0,277* 0,580**
Bodily pain 0,304** 0,181 −0,013 0,345** 0,168 0,427** 0,005 0,447** 0,357** 0,280* 0,411**
General health 0,366** 0,293** −0,005 0,340** 0,389** 0,511** 0,055 0,430** 0,252* 0,294** 0,440**
PCS SF36 0,124 0,081 −0,001 0,189 0,111 0,217* −0,097 0,254* 0,245* 0,214 0,198
MCS SF36 0,721** 0,545** 0,140 0,338** 0,567** 0,635** 0,240* 0,488** 0,239* 0,374** 0,703**
QoL VAS 0,545** 0,518** −0,023 0,348** 0,551** 0,636** 0,088 0,620** 0,376** 0,304** 0,669**
Burden VAS −0,232* −0,622** 0,013 −0,317** −0,295** −0,249* 0,040 −0,289** −0,086 −0,260* −0,396**
PsWB psychological well being, B burden, RHC relationship with healthcare, AF administration and finances, COP coping, PhWB physical well being, SE self-esteem,
LEI leisure time, SS social support, PL private life; range [0–100]; higher score indicated higher QoL
SF-36 dimensions, PCS SF36 physical composite score, MCS SF36 mental composite score; range [0–100]; higher score indicated higher QoL
VAS QoL, range [0–10], higher score indicated higher QoL; VAS Burden, range [0–10]; higher score indicated higher burden
*p < 0.05, **p < 0.01, ***p < 0.001
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Table 4 Comparisons (mean ± standard deviation) and correlations (r) of CarGOQoL scores with respect to caregivers’ and patients’
characteristics












































p value 0,001 0,441 0,035 0,582 0,432 0,040 0,386 0,149 0,455 0,615 0,123
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10,48
























































































50 ± 25,37 69,09 ±
11,15






















p value 0,219 0,159 0,405 0,096 0,160 0,511 0,916 0,319 0,282 0,681 0,117
Patient’s disease duration
r 0,061 −0,110 −0,168 0,007 −0,030 0,024 −0,070 −0,094 −0,299** −0,264* −0,187
0,582 0,317 0,127 0,952 0,785 0,832 0,524 0,396 0,006 0,019 0,104
Caregiving duration
r −0,010 −0,091 −0,109 −0,137 −0,018 −0,076 0,016 −0,302** −0,413** −0,204 −0,248*
p value 0,929 0,423 0,336 0,233 0,878 0,505 0,885 0,006 0,000 0,079 0,034
PsWB psychological well being, B burden, RHC relationship with healthcare, AF administration and finances, COP coping, PhWB physical well being, SE self-esteem,
LEI leisure time, SS social support, PL private life, range [0–100]; higher score indicated higher QoL
Bold values: p-value<0.05
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The absence of DIF supports the good quality of the
translation.
The availability of an American version of CarGOQoL
will enable clinical investigators to incorporate an assess-
ment of the CarGOQoL into their studies. Providing
multiple language versions of a questionnaire allows re-
searchers to pool data from different countries in multi-
national studies, to compare scores between countries
and to establish norms. From this American version,
other versions should be provided (such as an English
version for United Kingdom and Australia). In this case,
the standard process consists of a slighter cultural
adaptation process. The American version will be con-
sidered the “mother” language, which will be adapted to
the cultural and linguistic context of the target country.
Compared to other instruments assessing QoL of care-
givers of cancer patients, the CarGOQoL has at least
two interesting specificities. First, the questionnaire is
designed to reflect the exclusive point of view held by
caregivers themselves obtained from face-to-face, semi-
structured interviews based on guidelines from the lit-
erature [23]. The questionnaire allows for the identifica-
tion of specific dimensions, such as Self-esteem, that
focus on positive aspects of caregiving [2], or Private life,
Table 5 Reproducibility at day- 30 and day- 90
Day- 30 Day- 90
No life eventsa No health changesb No life eventsa No health changesb
Dimension N = 17 N = 39 N = 19 N = 29
Psychological well being 0.64 0.57 0.65 0.54
Burden 0.88 0.74 0.80 0.60
Relationship with healthcare 0.53 0.46 0.43 0.60
Administration and finances 0.88 0.78 0.73 0.81
Coping 0.77 0.72 0.66 0.92
Physical well being 0.84 0.60 0.87 0.69
Self-esteem 0.67 0.74 0.48 0.59
Leisure time 0.88 0.72 0.70 0.69
Social support 0.63 0.52 0.53 0.58
Private life 0.75 0.48 0.60 0.49
Index 0.94 0.65 0.80 0.82
ICC Intraclass correlation coefficients
a stable caregivers defined as no positive or negative changes in caregivers’ lives
b stable caregivers defined as a patient’s stable health status
Table 6 Sensitivity to change at day- 30 and day- 90: patient’s health status evolution reported by the caregiver
Day- 30 Day- 90
Improved Worsened Improved Worsened
N = 20 N = 19 N = 24 N = 18
Dimension Deltaa Deltaa Deltaa Deltaa
Psychological well being −6.67 4.28 −11.46** 9.19*
Burden 0.63 8.88 1.91 5.02
Relationship with healthcare 9.58 4.63 6.60* 4.17
Administration and finances −2.91 3.43 −4.69 −7.03*
Coping −3.33 3.24 −4.86 6.62
Physical well being −0.31 4.51 0.78 7.99
Self-esteem 7.50 3.29 0 −0.78
Leisure time 8.13* 4.61 4.69 −0.74
Social support 5.00 1.97 9.89* −8.82
Private life 0.66 10.29 4.67 3.57
Index 2.21 3.61 0.75 4.00
a Delta: change between day-0 and day-i (score day-0 – score day-i)
*p < 0.05, **p < 0.001
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which is not addressed in other questionnaires. Other ques-
tionnaires generally were developed by combining mixed
points of views from caregivers, patients and experts and
did not assess these specific dimensions [13, 14]. The
American linguistic validation process was performed using
the original French version in close collaboration with the
French developers. This rigorous approach ensured that the
translation faithfully reflected the original concepts in the
initial questionnaire. Second, the CarGOQoL was initially
validated on a large heterogeneous group of cancer care-
givers, which included partners, parents and children. This
accurately represents cancer patient relationships and cap-
tures all aspects of caregiver QoL. A large majority of previ-
ous studies focused on specific family relationships, such as
spouses, parents, or children. Finally, the low rate of miss-
ing data and the short time of completion assure future use
of this measure and make the CarGOQoL fully compatible
with clinical practice.
The psychometric properties of the American version of
the CarGOQoL can be considered satisfactory. Three items
had INFIT statistics outside the range [0.7-1.2]. This range
is applicable in the case of the development of a new test,
but is larger in the case of an existing test, ranging from 0.5
to 1.5 [24]. In accordance with this interpretation, item 8
(“… been embarrassed to be the only person to provide as-
sistance”) was the only item with an unacceptable range.
We hypothesized that “assistance” is not identically under-
stood by an American population compared to a French
population. In the case of an existing test, the overfitting
needs no action [25]. The study design allowed us to assess
core psychometric properties, such as reproducibility and
sensitivity to change, which are two core psychometric
properties of a measuring instrument [26, 27]. This study
showed that the CarGOQoL may be incorporated into lon-
gitudinal studies to detect a meaningful QoL change in can-
cer caregivers. As a specific QoL instrument that focuses
on particular life problems, the CarGOQoL is sensitive
enough to detect and quantify small changes. In accordance
with the US Food and Drug Administration and the Euro-
pean Medicines Agency which encourages the use of QoL
assessments, the CarGOQoL may be more appropriate
than generic questionnaires due to its better ability to dis-
cern QoL differences in cancer caregivers. This measure
could be used to monitor response to any intervention. An
examination of responsiveness requires longitudinal data
collection and is, therefore, rarely used in studies reporting
the validation of QoL questionnaires. Finally, environmen-
tal barriers have been described [28] to explain why QoL
measures have not been routinely implemented in clinical
practice and clinical research. A great asset of a QoL ques-
tionnaire is its acceptability. The low rate of missing data
and the short time of completion ensure the future use of
this measure and make the CarGOQoL fully compatible
with clinical practice.
The demographics of the French and American samples
varied slightly. The American sample has a similar sex-
ratio to the French sample used in the validation study of
the initial French version of CarGOQoL. The American
caregivers were older than the French caregivers (60+/−
11 vs. 52 +/− 14 [15]) and reported a shorter duration of
caregiving. The majority of American caregivers were
partners. Children and parents were underrepresented
compared to the French sample. Indeed, the French sam-
ple contained an important contingent of caretakers who
were predominantly parents due to the large number of
haematological cancers affecting young patients in the
French sample.
Some limitations should be considered. The major limi-
tation is the small sample size, which requires replication
of these findings in larger groups of caregivers. Likewise,
some indicators of internal structural validity were some-
times not optimal. The degree to which the American
structure matches the initial French structure should also
be quantified. This quantification has already be applied
using suitability indices [29]. These indices, which were
produced from decision rules to define satisfactory prop-
erties according to appropriate standards [23, 30], allow
for a more objective determination of the suitability or un-
suitability of different structures.
Conclusion
Despite some non-optimal indicators of validity, the
American version of the CarGOQoL constitutes a useful,
clinical instrument to measure QoL in caregivers of cancer
patients in the United States. Further linguistic validation
will be done using the English version of CarGOQoL for
caregivers in the United Kingdom, Canada, and Australia
to provide appropriate translations that are culturally rele-
vant and conceptually equivalent to the original.
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